z-logo
open-access-imgOpen Access
A Self‐Degradable Conjugated Polymer for Photodynamic Therapy with Reliable Postoperative Safety
Author(s) -
Huang Hongye,
Xie Wensheng,
Wan Qing,
Mao Liucheng,
Hu Danning,
Sun Hua,
Zhang Xiaoyong,
Wei Yen
Publication year - 2022
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202104101
Subject(s) - conjugated system , phototoxicity , photodynamic therapy , polymer , reactive oxygen species , chemistry , photochemistry , materials science , nanotechnology , in vitro , organic chemistry , biochemistry
As a noninvasive therapeutic technique, photodynamic therapy (PDT) has attracted numerous research interests for cancer therapy. Nevertheless, the residual photosensitizers (PSs) still produce reactive oxygen species (ROS) and damage normal cells under sunlight after PDT, which limits their practical application in clinic. Herein, the authors propose a self‐degradable type‐I PS based on conjugated polymer, which is composed of aggregation‐induced emission (AIE) and imidazole units. Due to the effective conjugated skeleton and unique AIE properties, thus‐obtained polymers can effectively generate superoxide radical (O 2 −• ) through the type‐I process under light irradiation, which is ideal for hypoxic tumors treatment. Intriguingly, under light irradiation, O 2 −• produced by the conjugated polymers can further lead to the self‐degradation of the polymer to form nontoxic micro‐molecules. It not only helps to resolve the potential phototoxicity problems of residual PSs, but also can accelerate the metabolism of the conjugated polymers to avoid the potential biotoxicity of drug accumulation. This work develops a self‐degradable type‐I PS, which can turn off the generation of ROS in time after PDT, providing a novel strategy to balance the PDT effect and postoperative safety.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here